BRENT KELSCH: Open Payments
NPI 1891187340 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 77 payments from 20 companies in 2025. Trend: 2023 $1,187 · 2024 $1,672 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $453 |
| AstraZeneca Pharmaceuticals LP | 7 | $230 |
| Novo Nordisk Inc | 9 | $165 |
| Lilly USA, LLC | 4 | $76 |
| Dexcom, Inc. | 3 | $65 |
| TOLMAR, INC. | 3 | $54 |
| Astellas Pharma US Inc | 3 | $54 |
| PFIZER INC. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Eisai Inc. | 1 | $37 |
Products named: QULIPTA, AIRSUPRA, VRAYLAR, UBRELVY, Ozempic, MOUNJARO, Dexcom G6 Transmitter, Wegovy.
Industry payments across AZ — which companies pay providers there.
